V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003405 | 10002165 | 1.59 | 68.8 | Adjuvant (A) | 2017-04-15 | 2017-04-15 | BCG Intravesical | N | N | 10475843 | FLUOROURACIL + MITOMYCIN + RT |
| 10003406 | 10002166 | 1.82 | 66.3 | Adjuvant (A) | 2017-09-30 | 2017-10-02 | FEC 100 + DOCETAXEL | 2 | Y | 10475887 | FEC + DOCETAXEL |
| 10003407 | 10002167 | 1.68 | 55.7 | Palliative (P) | 2019-03-14 | 2019-04-05 | CTD | N | N | 10475890 | FLUOROURACIL + MITOMYCIN + RT |
| 10003408 | 10002168 | 1.74 | 101.5 | Disease modification (D) | 2016-06-01 | 2016-06-04 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | null | 10475922 | BORTEZOMIB |
| 10003409 | 10002168 | null | 96.3 | Adjuvant (A) | 2014-07-05 | 2014-07-17 | Bortezomib +/- Dexamethasone | N | N | 10475922 | AZACITIDINE |
| 10003410 | 10002168 | 1.56 | 60.7 | Curative (C) | 2017-05-31 | 2017-06-16 | Capecitabine 35days + RT | 2 | Y | 10475922 | CAPECITABINE + RT |
| 10003411 | 10002168 | 1.58 | null | Palliative (P) | 2018-06-05 | 2018-06-05 | EC | N | N | 10475922 | ABVD |
| 10003412 | 10002169 | 1.72 | 96 | Adjuvant (A) | 2015-05-09 | 2015-05-25 | Capecitabine + Cisplatin | N | N | 10476222 | BCG |
| 10003413 | 10002170 | 1.84 | 81 | Disease modification (D) | 2017-10-27 | 2017-11-11 | Azacitidine | null | Y | 10476241 | BORTEZOMIB |
| 10003414 | 10002171 | 1.74 | 81.8 | Neo-adjuvant (N) | 2017-01-03 | 2017-01-30 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 10476270 | BCG |
| 10003415 | 10002172 | 1.75 | 76 | Palliative (P) | 2018-09-08 | 2018-09-29 | EC | 02 | N | 10476284 | ABVD |
| 10003416 | 10002173 | null | 81.8 | Curative (C) | null | 2017-06-02 | PACLITAXEL | null | null | 10476294 | PACLITAXEL |
| 10003417 | 10002174 | 0 | null | Adjuvant (A) | 2014-02-28 | 2014-03-13 | FEC + DOCETAXEL | N | N | 10476303 | FEC + DOCETAXEL |
| 10003418 | 10002175 | 1.73 | 62.3 | Palliative (P) | 2015-09-29 | 2015-09-29 | ABVD | N | N | 10476353 | CAPECITABINE + CISPLATIN |
| 10003419 | 10002175 | null | 83.1 | Disease modification (D) | 2017-10-27 | 2017-11-14 | Abiraterone | 2 | Y | 10476353 | PACLITAXEL |
| 10003420 | 10002176 | 1.72 | null | null | 2014-09-04 | 2014-09-04 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10476426 | FLUOROURACIL + MITOMYCIN + RT |
| 10003421 | 10002177 | null | null | Curative (C) | 2019-01-16 | 2019-01-20 | IMATINIB | 02 | N | 10476510 | CISPLATIN + ETOPOSIDE |
| 10003422 | 10002178 | 1.8 | 75 | Curative (C) | 2017-07-06 | 2017-07-08 | Abiraterone | 02 | N | 10476629 | CVD |
| 10003423 | 10002179 | 1.77 | 0 | Palliative (P) | 2018-03-14 | 2018-03-15 | Paclitaxel 7 day | 02 | null | 10476675 | ABVD |
| 10003424 | 10002179 | null | 77.1 | Curative (C) | 2018-03-28 | 2018-04-19 | Cisplatin + Radiotherapy | 2 | Y | 10476675 | CISPLATIN + RT |
| 10003425 | 10002179 | 1.57 | 68.4 | Palliative (P) | 2017-01-28 | 2017-02-17 | CAPECITABINE + GEMCITABINE | 02 | N | 10476675 | ABIRATERONE |
| 10003426 | 10002180 | 1.7 | 81.8 | Palliative (P) | 2018-12-27 | 2018-12-30 | Irinotecan + Modified De Gramont | N | N | 10476927 | IRINOTECAN + MDG |
| 10003427 | 10002181 | 1.65 | 67.4 | Curative (C) | 2017-03-17 | 2017-03-17 | Bortezomib +/- Dexamethasone | N | N | 10476963 | CTD |
| 10003428 | 10002182 | 1.65 | 80.2 | Adjuvant (A) | 2018-01-12 | 2018-01-18 | EC | 02 | N | 10477059 | CVD |
| 10003429 | 10002183 | 1.62 | 75.9 | Not known (9) | 2016-08-26 | 2016-08-26 | FLUOROURACIL | N | null | 10477107 | FLUOROURACIL |
| 10003430 | 10002183 | 1.49 | 85 | Palliative (P) | 2018-01-30 | 2018-01-30 | Azacitidine | 2 | N | 10477107 | CHLORAMBUCIL |
| 10003431 | 10008088 | 1.6 | 90 | Disease modification (D) | 2018-01-14 | 2018-01-14 | Gemcitabine + Capecitabine | 02 | N | 10477363 | TEMOZOLOMIDE + RT |
| 10003432 | 10008088 | 1.57 | 48.2 | Palliative (P) | 2016-07-28 | 2016-07-30 | Irinotecan + Modified De Gramont | N | N | 10477363 | IRINOTECAN + MDG |
| 10003433 | 10002184 | 1.64 | null | Curative (C) | 2017-03-06 | 2017-03-06 | FEC + DOCETAXEL | N | N | 10477382 | FEC + DOCETAXEL |
| 10003434 | 10002185 | 1.6 | 69.5 | Curative (C) | 2017-02-05 | 2017-02-21 | Bortezomib + CYCLOPHOSPHAMIDE + Dexamethasone | N | N | 10477547 | CAPECITABINE + CISPLATIN |
| 10003435 | 10006424 | 0 | 82.2 | Curative (C) | 2018-07-18 | 2018-08-07 | CISPLATIN + RT | N | Y | 10477552 | CISPLATIN + RT |
| 10003436 | 10002186 | 1.61 | 66.7 | null | 2015-01-23 | 2015-01-23 | BCG Intravesical | 02 | N | 10477581 | TEMOZOLOMIDE + RT |
| 10003437 | 10002186 | 1.71 | 0 | Adjuvant (A) | 2014-10-02 | 2014-10-02 | Cisplatin 7 day | N | N | 10477581 | CISPLATIN |
| 10003438 | 10002187 | 1.73 | 60 | Neo-adjuvant (N) | 2017-07-26 | 2017-07-31 | FEC + DOCETAXEL | 02 | N | 10477757 | FEC + DOCETAXEL |
| 10003439 | 10002188 | 1.84 | 64.5 | Curative (C) | null | 2013-12-25 | EC | N | N | 10477854 | PACLITAXEL |
| 10003440 | 10002188 | 1.68 | null | Curative (C) | 2014-11-01 | 2014-11-11 | Temozolomide + RT | N | N | 10477854 | CVD |
| 10003441 | 10008089 | 1.54 | 64.2 | Not known (9) | 2014-08-10 | 2014-08-11 | EC | N | N | 10478363 | CTD |
| 10003442 | 10002189 | 1.74 | null | Curative (C) | 2018-06-15 | 2018-06-30 | PACLITAXEL | N | Y | 10478428 | CTD |
| 10003443 | 10006427 | 1.7 | 111.2 | Palliative (P) | 2014-08-18 | 2014-08-30 | CTD Attenuated (Thalidomide 50mg) | N | N | 10478429 | CTD |
| 10003444 | 10002190 | 1.76 | 85 | Disease modification (D) | null | 2015-10-15 | EC | N | N | 10478482 | ABIRATERONE |
| 10003445 | 10002191 | null | null | Curative (C) | 2017-07-03 | 2017-08-06 | CISPLATIN + RT | Y | Y | 10478486 | CISPLATIN + RT |
| 10003446 | 10006428 | 1.75 | 96 | Curative (C) | 2016-08-19 | 2016-08-19 | EC | N | N | 10478532 | CAPECITABINE + GEMCITABINE |
| 10003447 | 10008090 | null | 56.7 | Adjuvant (A) | 2018-06-19 | 2018-07-01 | Fluorouracil + Folinic Acid Weekly | 02 | N | 10478563 | FLUOROURACIL |
| 10003448 | 10002192 | 1.64 | 71.2 | Disease modification (D) | 2015-04-22 | 2015-10-09 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 10478608 | CHOP |
| 10003449 | 10002193 | 1.61 | 82 | Neo-adjuvant (N) | 2017-02-03 | 2017-02-05 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | 10478963 | ABVD |
| 10003450 | 10002193 | 1.79 | 88.7 | Neo-adjuvant (N) | 2014-02-16 | 2014-02-21 | Bortezomib +/- Dexamethasone | N | N | 10478963 | CAPECITABINE + GEMCITABINE |
| 10003451 | 10002193 | null | 73.2 | Neo-adjuvant (N) | 2017-04-08 | 2017-04-08 | FEC 100 + DOCETAXEL | null | N | 10478963 | FEC + DOCETAXEL |
| 10003452 | 10002193 | 1.65 | 66.6 | Palliative (P) | 2016-10-22 | 2016-10-23 | Imatinib 400mg | 02 | N | 10478963 | CVD |
| 10003453 | 10002194 | 0 | 90.4 | Palliative (P) | 2013-07-03 | 2013-07-11 | CISPLATIN + RT | N | Y | 10479023 | CISPLATIN + RT |
| 10003454 | 10002195 | 1.67 | 0 | Curative (C) | 2016-02-19 | 2016-02-29 | Fluorouracil+Mitomycin+RT (Bladder) | 02 | N | 10479078 | EC |